Systemic vs Local Efficacy
BPC-157 (Body Protective Compound-157) is a peptide originally isolated from human gastric juice. While it is highly prized as a subcutaneous injection for tendon and ligament repair, its oral bioavailability is uniquely high compared to other peptides. When taken orally, BPC-157 acts profoundly on the gastrointestinal tract, bypassing systemic circulation to act locally on inflamed gut mucosa.
For systemic musculoskeletal injuries, inject; for GI disorders (GERD, IBS, leaky gut, ulcers), oral administration is vastly superior.
The Leaky Gut Protocol
Oral BPC-157 (often stabilized as an Arginate salt rather than acetate for survival in stomach acid) accelerates angiogenesis in the intestinal lining. It essentially "stitches" the tight junctions of the gut back together, halting intestinal permeability.
Dosage typically ranges from 250mcg to 500mcg taken orally twice daily, ideally on an empty stomach. Cycles run for 30 to 60 days depending on the severity of the dysbiosis or inflammation.
Stacking for Gut Health
Advanced biohackers frequently stack oral BPC-157 with KPV (Lysine-Proline-Valine), an extremely potent anti-inflammatory peptide. Where BPC-157 rebuilds the physical structure of the gut wall, KPV suppresses the runaway mast-cell activation and inflammation that characterizes conditions like Crohn's and ulcerative colitis.
Medical Disclaimer
These protocols are experimental. BPC-157 is banned by WADA and not approved by the FDA for the treatment of inflammatory bowel disease or any other medical condition. Consult a gastroenterologist.